ArticleResearch and practice in thrombosis and haemostasis2021

Thromboprophylaxis with rivaroxaban in patients with malignancy and central venous lines (TRIM-Line): A two-center open-label pilot randomized controlled trial.

Rick Ikesaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.